Mutations in TP53 and DNA damage repair genes have a negative impact on the response to first-line systemic therapy in men with prostate cancer

被引：0

作者：

Nientiedt, C. ^{[1
,2
]}

Wuenschel, A. -K ^{[3
]}

Kaczorowski, A. ^{[3
]}

Endris, V ^{[4
]}

Zschaebitz, S. ^{[1
]}

Jaeger, D. ^{[1
]}

Hohenfellner, M. ^{[5
]}

Stenzinger, A.

Duensing, S. ^{[3
]}

机构：

[1] NCT Natl Ctr Tumorerkrankungen Heidelberg, Med Onkol, Heidelberg, Germany

[2] Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany

[3] Urol Clin, Mol Uroonkol, Heidelberg, Germany

[4] Pathol Inst, Allgemeine Pathol, Heidelberg, Germany

[5] Urol Clin, Heidelberg, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V836

引用

页码：112 / 112

页数：1

共 50 条

[31] Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study [J].

Casadei, Chiara ;

Scarpi, Emanuela ;

Conteduca, Vincenza ;

Gurioli, Giorgia ;

Cursano, Maria Concetta ;

Brighi, Nicole ;

Lolli, Cristian ;

Schepisi, Giuseppe ;

Basso, Umberto ;

Fornarini, Giuseppe ;

Bleve, Sara ;

Farolfi, Alberto ;

Altavilla, Amelia ;

Burgio, Salvatore Luca ;

Giunta, Emilio Francesco ;

Gianni, Caterina ;

Filograna, Alessia ;

Ulivi, Paola ;

Olmos, David ;

Castro, Elena ;

De Giorgi, Ugo .

EUROPEAN UROLOGY OPEN SCIENCE, 2024, 61 :44-51

[32] The impact of previous hormone therapy on psa response to liarozole in prostate cancer patients failing first-line androgen ablation [J].

Rassweiler, JJ .

JOURNAL OF UROLOGY, 1998, 159 (05) :131-131

[33] Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer [J].

Prive, Bastiaan M. ;

Slootbeek, Peter H. J. ;

Laarhuis, Babette, I ;

Naga, Samhita Pamidimarri ;

van Der Doelen, Maarten J. ;

van Kalmthout, Ludwike W. M. ;

de Keizer, Bart ;

Ezziddin, Samer ;

Kratochwil, Clemens ;

Morgenstern, Alfred ;

Bruchertseifer, Frank ;

Ligtenberg, Marjolijn J. L. ;

Witjes, J. Alfred ;

van Oort, Inge M. ;

Gotthardt, Martin ;

Heskamp, Sandra ;

Janssen, Marcel J. R. ;

Gerritsen, Winald R. ;

Nagarajah, James ;

Mehra, Niven .

PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (01) :71-78

[34] Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer [J].

Bastiaan M. Privé ;

Peter H. J. Slootbeek ;

Babette I. Laarhuis ;

Samhita Pamidimarri Naga ;

Maarten J. van der Doelen ;

Ludwike W. M. van Kalmthout ;

Bart de Keizer ;

Samer Ezziddin ;

Clemens Kratochwil ;

Alfred Morgenstern ;

Frank Bruchertseifer ;

Marjolijn J. L. Ligtenberg ;

J. Alfred Witjes ;

Inge M. van Oort ;

Martin Gotthardt ;

Sandra Heskamp ;

Marcel J. R. Janssen ;

Winald R. Gerritsen ;

James Nagarajah ;

Niven Mehra .

Prostate Cancer and Prostatic Diseases, 2022, 25 :71-78

[35] Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy. [J].

Lavery, Jessica A. ;

Brown, Samantha ;

Riely, Gregory J. ;

Bedard, Philippe L. ;

Park, Ben Ho ;

Warner, Jeremy Lyle ;

Kehl, Kenneth L. ;

Lepisto, Eva M. ;

Rizvi, Hira ;

LeNoue-Newton, Michele ;

McCarthy, Caroline G. ;

Yu, Celeste ;

Kundra, Ritika ;

Mastrogiacomo, Brooke ;

Schultz, Nikolaus ;

Rudolph, Julia Elizabeth ;

Sweeney, Shawn ;

Schrag, Deborah ;

Panageas, Katherine .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[36] Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer [J].

Eustace, Alex J. ;

Lee, Min Jie ;

Colley, Grace ;

Roban, Jack ;

Downing, Tim ;

Buchanan, Paul J. .

CANCER DRUG RESISTANCE, 2022, 5 (03) :560-576

[37] Germline mutations in DNA damage repair genes and HOXB13 among African American men diagnosed with early-onset prostate cancer. [J].

Beebe-Dimmer, Jennifer Lynn ;

Sample, Christopher ;

Baird, Tara ;

Sadeghpour, Azita ;

Ruterbusch, Julie J. ;

Cooney, Kathleen A. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[38] Germ line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms [J].

Schulz, E. ;

Valentin, A. ;

Ulz, P. ;

Beham-Schmid, C. ;

Lind, K. ;

Rupp, V ;

Lackner, H. ;

Woelfler, A. ;

Zebisch, A. ;

Olipitz, W. ;

Geigl, J. B. ;

Berghold, A. ;

Speicher, M. R. ;

Sill, H. .

ONKOLOGIE, 2012, 35 :117-117

[39] TP53 mutations in cell-free DNA as early marker of therapy response in platinum-resistant ovarian cancer: prospective translational analysis of the phase II GANNET53 clinical trial [J].

Vanderstichele, Adriaan .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) :451-451

[40] Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer [J].

Belaidi, Lahcene ;

Wang, Pascal ;

Quintin, Kevin ;

Durdux, Catherine ;

Giroux-Leprieur, Etienne ;

Giraud, Philippe .

CANCERS, 2023, 15 (21)

← 1 2 3 4 5 →